TotalMarketCap

Biomarin Pharmaceutical

BMRNNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$10.607 B

$54.80 -0.17%

Close of 12 Oct 2026

As of 12 Oct 2026, Biomarin Pharmaceutical (BMRN) has a market capitalization of $10.6B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$3.22B

#869 by revenue

Earnings

$348.9M

#766 by earnings

Shares outstanding

193,573,759

Latest filing cover page

P/E ratio

30.4

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →
  1. #31Elanco Animal HealthELAN$11.5B
  2. #32Madrigal PharmaceuticalsMDGL$10.9B
  3. #33Biomarin PharmaceuticalBMRN$10.6B
  4. #34Dr Reddys LaboratoriesRDY$10.4B
  5. #35Protagonist TherapeuticsPTGX$9.30B

What if Biomarin Pharmaceutical were worth as much as…

Open the what-if tool →

Gold $29.0T

$149,941.07

Per share 2,736× higher

Bitcoin $1.66T

$8,590.94

Per share 157× higher

Nvidia $5.53T

$28,545.44

Per share 521× higher

Or at a round number

$20.0B$50.0B$100.0B$200.0B

Where these numbers come from

Share counts and financials for Biomarin Pharmaceutical are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 13 Oct 2026. Read the methodology.